Comparison between Angel Broking IPO and Gland Pharma IPO.
Angel Broking IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Gland Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Angel Broking IPO is up to ₹600.00 Cr whereas the issue size of the Gland Pharma IPO is up to ₹6,479.55 Cr. The final issue price of Angel Broking IPO is ₹306.00 per share and of Gland Pharma IPO is ₹1,500.00 per share.
| Angel Broking IPO | Gland Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ₹305.00 per share | ₹1,490.00 per share |
| Issue Price (Upper) | ₹306.00 per share | ₹1,500.00 per share |
| Issue Price (Final) | ₹306.00 per share | ₹1,500.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 49 shares | 10 shares |
| Fresh Issue Size | 98,03,921 shares | 83,33,333 shares |
| Fresh Issue Size (Amount) | up to ₹300.00 Cr | up to ₹1,250.00 Cr |
| OFS Issue Size | 98,03,914 shares | 3,48,63,635 shares |
| OFS Issue Size (Amount) | up to ₹300.00 Cr | up to ₹5,229.55 Cr |
| Issue Size Total | 1,96,07,835 shares | 4,31,96,968 shares |
| Issue Size Total (Amount) | up to ₹600.00 Cr | up to ₹6,479.55 Cr |
Angel Broking IPO opens on Sep 22, 2020, while Gland Pharma IPO opens on Nov 09, 2020. The closing date of Angel Broking IPO and Gland Pharma IPO is Sep 24, 2020, and Nov 11, 2020, respectively.
| Angel Broking IPO | Gland Pharma IPO | |
|---|---|---|
| Anchor Bid Date | Sep 21, 2020 | Nov 06, 2020 |
| Issue Open | Sep 22, 2020 | Nov 09, 2020 |
| Issue Close | Sep 24, 2020 | Nov 11, 2020 |
| Basis Of Allotment (Tentative) | Sep 29, 2020 | Nov 17, 2020 |
| Initiation of Refunds (Tentative) | Sep 30, 2020 | Nov 18, 2020 |
| Credit of Share (Tentative) | Oct 01, 2020 | Nov 19, 2020 |
| Listing date (Tentative) | Oct 05, 2020 | Nov 20, 2020 |
| Anchor Lockin End date 1 | Oct 29, 2020 | Dec 17, 2020 |
| Anchor Lockin End date 2 | Dec 28, 2020 | Feb 15, 2021 |
Angel Broking IPO P/E ratio is , as compared to Gland Pharma IPO P/E ratio of .
| Angel Broking IPO | Gland Pharma IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 65.42 | 74 | ||||
| Promoter Shareholding (Post-Issue) | 58 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹2503.05 Cr. | ₹24492.42 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Angel Broking IPO Retail Individual Investors (RII) are offered 68,62,743 shares while in Gland Pharma IPO retail investors are offered 68,62,743 shares. Qualified Institutional Buyers (QIB) are offered 39,21,564 shares in Angel Broking IPO and 86,39,394 shares in Gland Pharma IPO.
| Angel Broking IPO | Gland Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 58,82,352 shares | 1,29,59,089 shares |
| Market Maker Reservation | ||
| QIB | 39,21,564 shares | 86,39,394 shares |
| NII | 29,41,176 shares | 64,79,546 shares |
| RII | 68,62,743 shares | 1,51,18,939 shares |
| Employee | ||
| Others | ||
| Total | 1,96,07,835 shares | 4,31,96,968 shares |
Angel Broking IPO subscribed 3.94x in total, whereas Gland Pharma IPO subscribed 2.06x.
| Angel Broking IPO | Gland Pharma IPO | |
|---|---|---|
| QIB (times) | 5.74x | 6.40x |
| NII (times) | 0.69x | 0.51x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.31x | 0.24x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 3.94x | 2.06x |
